Abeona Therapeutics (ABEO) Competitors $6.58 +0.17 (+2.57%) As of 02:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO vs. PCRX, OCUL, CALT, BGM, DVAX, AMPH, INVA, ETNB, AUPH, and OPKShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Pacira BioSciences (PCRX), Ocular Therapeutix (OCUL), Calliditas Therapeutics AB (publ) (CALT), Qilian International Holding Group (BGM), Dynavax Technologies (DVAX), Amphastar Pharmaceuticals (AMPH), Innoviva (INVA), 89bio (ETNB), Aurinia Pharmaceuticals (AUPH), and OPKO Health (OPK). These companies are all part of the "pharmaceutical preparations" industry. Abeona Therapeutics vs. Pacira BioSciences Ocular Therapeutix Calliditas Therapeutics AB (publ) Qilian International Holding Group Dynavax Technologies Amphastar Pharmaceuticals Innoviva 89bio Aurinia Pharmaceuticals OPKO Health Abeona Therapeutics (NASDAQ:ABEO) and Pacira BioSciences (NASDAQ:PCRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings. Is ABEO or PCRX more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Pacira BioSciences' net margin of -13.07%. Pacira BioSciences' return on equity of 13.42% beat Abeona Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Abeona TherapeuticsN/A -203.27% -64.56% Pacira BioSciences -13.07%13.42%7.19% Do analysts rate ABEO or PCRX? Abeona Therapeutics presently has a consensus target price of $18.50, suggesting a potential upside of 179.88%. Pacira BioSciences has a consensus target price of $26.44, suggesting a potential upside of 0.39%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Abeona Therapeutics is more favorable than Pacira BioSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Pacira BioSciences 1 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals & insiders have more ownership in ABEO or PCRX? 80.6% of Abeona Therapeutics shares are held by institutional investors. Comparatively, 99.7% of Pacira BioSciences shares are held by institutional investors. 6.9% of Abeona Therapeutics shares are held by insiders. Comparatively, 6.4% of Pacira BioSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media favor ABEO or PCRX? In the previous week, Abeona Therapeutics had 8 more articles in the media than Pacira BioSciences. MarketBeat recorded 18 mentions for Abeona Therapeutics and 10 mentions for Pacira BioSciences. Pacira BioSciences' average media sentiment score of 1.57 beat Abeona Therapeutics' score of 0.70 indicating that Pacira BioSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abeona Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Pacira BioSciences 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable earnings and valuation, ABEO or PCRX? Pacira BioSciences has higher revenue and earnings than Abeona Therapeutics. Pacira BioSciences is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbeona Therapeutics$3.50M92.16-$54.19M-$1.27-5.20Pacira BioSciences$702.77M1.74$41.96M-$2.28-11.55 Which has more volatility & risk, ABEO or PCRX? Abeona Therapeutics has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Comparatively, Pacira BioSciences has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Does the MarketBeat Community believe in ABEO or PCRX? Pacira BioSciences received 303 more outperform votes than Abeona Therapeutics when rated by MarketBeat users. Likewise, 71.58% of users gave Pacira BioSciences an outperform vote while only 69.38% of users gave Abeona Therapeutics an outperform vote. CompanyUnderperformOutperformAbeona TherapeuticsOutperform Votes52869.38% Underperform Votes23330.62% Pacira BioSciencesOutperform Votes83171.58% Underperform Votes33028.42% SummaryAbeona Therapeutics beats Pacira BioSciences on 10 of the 18 factors compared between the two stocks. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$323.30M$6.55B$5.40B$8.53BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-2.469.1626.7419.97Price / Sales92.16258.53394.93122.22Price / CashN/A65.8538.2534.62Price / Book11.026.546.874.59Net Income-$54.19M$143.98M$3.23B$248.18M7 Day Performance22.63%4.65%5.01%2.15%1 Month Performance34.35%9.18%12.82%16.14%1 Year Performance53.36%-1.33%17.63%8.06% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.8393 of 5 stars$6.59+2.6%$18.50+180.9%+44.3%$323.50M$3.50M-2.46N/AEarnings ReportAnalyst RevisionHigh Trading VolumePCRXPacira BioSciences2.1731 of 5 stars$26.15+1.1%$26.44+1.1%-12.6%$1.21B$702.77M-12.88720Positive NewsOCULOcular Therapeutix4.2938 of 5 stars$7.51+4.0%$16.25+116.4%+20.8%$1.20B$59.65M-5.69230Positive NewsCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180BGMQilian International Holding GroupN/A$12.18-2.9%N/AN/A$1.18B$25.10M0.00298Gap DownDVAXDynavax Technologies4.3059 of 5 stars$9.83+1.7%$24.00+144.2%-8.5%$1.18B$294.62M54.61350Positive NewsAMPHAmphastar Pharmaceuticals4.2878 of 5 stars$24.79-0.3%$32.33+30.4%-41.8%$1.18B$730.66M8.261,620INVAInnoviva4.3697 of 5 stars$18.63+0.3%$55.00+195.2%+16.4%$1.17B$369.84M27.00100News CoveragePositive NewsETNB89bio2.8861 of 5 stars$7.70-1.0%$26.43+243.2%+1.0%$1.12BN/A-2.6540Positive NewsAUPHAurinia Pharmaceuticals2.4527 of 5 stars$8.07-1.5%$11.50+42.5%+43.6%$1.09B$247.30M-53.80300OPKOPKO Health4.4533 of 5 stars$1.33flat$2.75+106.8%+0.8%$1.05B$689.41M-7.004,200Gap Up Related Companies and Tools Related Companies Pacira BioSciences Alternatives Ocular Therapeutix Alternatives Calliditas Therapeutics AB (publ) Alternatives Qilian International Holding Group Alternatives Dynavax Technologies Alternatives Amphastar Pharmaceuticals Alternatives Innoviva Alternatives 89bio Alternatives Aurinia Pharmaceuticals Alternatives OPKO Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABEO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABEO Stock Free ABEO Stock Alerts